ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED

Core Viewpoint - ZimVie Inc. has received approval from its stockholders for the acquisition by an affiliate of ARCHIMED, with the merger expected to close on October 20, 2025, pending all conditions being met [1][2]. Company Overview: ZimVie - ZimVie is a global leader in the dental implant market, focusing on developing, manufacturing, and delivering a wide range of products for dental tooth replacement and restoration [3]. - The company aims to enhance smiles, function, and confidence through its comprehensive solutions, which include dental implants, biomaterials, and digital workflow solutions [3]. - ZimVie operates from its headquarters in Palm Beach Gardens, Florida, and has additional facilities worldwide [3]. Company Overview: ARCHIMED - ARCHIMED is a prominent investment firm with a focus on healthcare industries, operating in Europe, North America, and Asia [4]. - The firm combines operational, medical, scientific, and financial expertise to act as both a strategic and financial partner for healthcare businesses [4]. - ARCHIMED manages €8 billion across various funds and emphasizes impact investing through its EURÊKA Foundation [4].